- Home
- ADAG vs IAE Comparison
ADAG vs IAE Comparison
Compare ADAG & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- IAE
- Stock Information
- Founded
- ADAG 2011
- IAE 2007
- Country
- ADAG China
- IAE United States
- Employees
- ADAG N/A
- IAE N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- IAE Trusts Except Educational Religious and Charitable
- Sector
- ADAG Health Care
- IAE Finance
- Exchange
- ADAG Nasdaq
- IAE Nasdaq
- Market Cap
- ADAG 81.9M
- IAE 65.2M
- IPO Year
- ADAG 2021
- IAE N/A
- Fundamental
- Price
- ADAG $1.60
- IAE $6.27
- Analyst Decision
- ADAG Strong Buy
- IAE
- Analyst Count
- ADAG 1
- IAE 0
- Target Price
- ADAG $8.00
- IAE N/A
- AVG Volume (30 Days)
- ADAG 15.4K
- IAE 46.3K
- Earning Date
- ADAG 03-24-2025
- IAE 01-01-0001
- Dividend Yield
- ADAG N/A
- IAE 10.21%
- EPS Growth
- ADAG N/A
- IAE N/A
- EPS
- ADAG N/A
- IAE N/A
- Revenue
- ADAG $103,204.00
- IAE N/A
- Revenue This Year
- ADAG $6,488.89
- IAE N/A
- Revenue Next Year
- ADAG $57.50
- IAE N/A
- P/E Ratio
- ADAG N/A
- IAE N/A
- Revenue Growth
- ADAG N/A
- IAE N/A
- 52 Week Low
- ADAG $1.33
- IAE $5.31
- 52 Week High
- ADAG $3.58
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- ADAG 51.88
- IAE 61.01
- Support Level
- ADAG $1.51
- IAE $6.19
- Resistance Level
- ADAG $1.74
- IAE $6.33
- Average True Range (ATR)
- ADAG 0.10
- IAE 0.09
- MACD
- ADAG 0.03
- IAE 0.03
- Stochastic Oscillator
- ADAG 61.84
- IAE 87.76
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.